APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ketorolac Injection

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Ketorolac Injection Market Analysis and Forecast 2026-2032

22 December 2025198 pages

Choose your research edition.

Industry ResearchKetorolac Injection Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Ketorolac Injection Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Ketorolac Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ketorolac Injection Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Ketorolac Injection Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Ketorolac Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Ketorolac Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Ketorolac Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Ketorolac Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Ketorolac Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Ketorolac Injection include Pfizer, Fresenius Kabi, Fosun Pharma (Gland Pharma), Sagent Pharmaceuticals, Hikma, Lunan Pharma, Alvogen, Chengdu Brilliant Pharmaceuticals and Athenex, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Ketorolac Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Ketorolac Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Ketorolac Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Ketorolac Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Ketorolac Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Ketorolac Injection sales, projected growth trends, production technology, application and end-user industry.

Ketorolac Injection Segment by Company

Pfizer

Fresenius Kabi

Fosun Pharma (Gland Pharma)

Sagent Pharmaceuticals

Hikma

Lunan Pharma

Alvogen

Chengdu Brilliant Pharmaceuticals

Athenex

Sichuan Medcalo

Julphar Bangladesh Ltd.

Yung Shin Pharm

Tianjin Chase Sun Pharmaceutical

ZISKA Pharmaceuticals

Ketorolac Injection Segment by Concentration

15mg/ml

30mg/ml

Ketorolac Injection Segment by Application

Hospital

Clinics

Others

Ketorolac Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ketorolac Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ketorolac Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ketorolac Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Ketorolac Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Ketorolac Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Ketorolac Injection sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Ketorolac Injection Market Size Growth Rate by Concentration (US$ Million), 2021 VS 2025 VS 2032 Table 2. 15mg/ml Major Manufacturers Table 3. 30mg/ml Major Manufacturers Table 4. Global Ketorolac Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Clinics Major Manufacturers Table 7. Others Major Manufacturers Table 8. Ketorolac Injection Industry Trends Table 9. Ketorolac Injection Industry Drivers Table 10. Ketorolac Injection Industry Opportunities and Challenges Table 11. Ketorolac Injection Industry Restraints Table 12. Global Ketorolac Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Ketorolac Injection Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Ketorolac Injection Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Ketorolac Injection Revenue Market Share by Region (2021-2026) Table 16. Global Ketorolac Injection Revenue Market Share by Region (2027-2032) Table 17. Global Ketorolac Injection Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Ketorolac Injection Sales by Region (2021-2026) & (K Units) Table 19. Global Ketorolac Injection Sales by Region (2027-2032) & (K Units) Table 20. Global Ketorolac Injection Sales Market Share by Region (2021-2026) Table 21. Global Ketorolac Injection Sales Market Share by Region (2027-2032) Table 22. Global Ketorolac Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Ketorolac Injection Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Ketorolac Injection Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Ketorolac Injection Sales Market Share by Manufacturers (2021-2026) Table 26. Global Ketorolac Injection Sales Price (US$/K Units) of Manufacturers (2021-2026) Table 27. Global Ketorolac Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Ketorolac Injection Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Ketorolac Injection Manufacturers, Product Type & Application Table 30. Global Ketorolac Injection Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Ketorolac Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Ketorolac Injection Revenue by Concentration 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Ketorolac Injection Revenue by Concentration (2021-2026) & (US$ Million) Table 35. Global Ketorolac Injection Revenue by Concentration (2027-2032) & (US$ Million) Table 36. Global Ketorolac Injection Revenue Market Share by Concentration (2021-2026) Table 37. Global Ketorolac Injection Revenue Market Share by Concentration (2027-2032) Table 38. Global Ketorolac Injection Sales by Concentration 2021 VS 2025 VS 2032 (K Units) Table 39. Global Ketorolac Injection Sales by Concentration (2021-2026) & (K Units) Table 40. Global Ketorolac Injection Sales by Concentration (2027-2032) & (K Units) Table 41. Global Ketorolac Injection Sales Market Share by Concentration (2021-2026) Table 42. Global Ketorolac Injection Sales Market Share by Concentration (2027-2032) Table 43. Global Ketorolac Injection Price by Concentration (2021-2026) & (US$/K Units) Table 44. Global Ketorolac Injection Price by Concentration (2027-2032) & (US$/K Units) Table 45. Global Ketorolac Injection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Ketorolac Injection Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Ketorolac Injection Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Ketorolac Injection Revenue Market Share by Application (2021-2026) Table 49. Global Ketorolac Injection Revenue Market Share by Application (2027-2032) Table 50. Global Ketorolac Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Ketorolac Injection Sales by Application (2021-2026) & (K Units) Table 52. Global Ketorolac Injection Sales by Application (2027-2032) & (K Units) Table 53. Global Ketorolac Injection Sales Market Share by Application (2021-2026) Table 54. Global Ketorolac Injection Sales Market Share by Application (2027-2032) Table 55. Global Ketorolac Injection Price by Application (2021-2026) & (US$/K Units) Table 56. Global Ketorolac Injection Price by Application (2027-2032) & (US$/K Units) Table 57. Pfizer Company Information Table 58. Pfizer Business Overview Table 59. Pfizer Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 60. Pfizer Ketorolac Injection Product Portfolio Table 61. Pfizer Recent Development Table 62. Fresenius Kabi Company Information Table 63. Fresenius Kabi Business Overview Table 64. Fresenius Kabi Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 65. Fresenius Kabi Ketorolac Injection Product Portfolio Table 66. Fresenius Kabi Recent Development Table 67. Fosun Pharma (Gland Pharma) Company Information Table 68. Fosun Pharma (Gland Pharma) Business Overview Table 69. Fosun Pharma (Gland Pharma) Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 70. Fosun Pharma (Gland Pharma) Ketorolac Injection Product Portfolio Table 71. Fosun Pharma (Gland Pharma) Recent Development Table 72. Sagent Pharmaceuticals Company Information Table 73. Sagent Pharmaceuticals Business Overview Table 74. Sagent Pharmaceuticals Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 75. Sagent Pharmaceuticals Ketorolac Injection Product Portfolio Table 76. Sagent Pharmaceuticals Recent Development Table 77. Hikma Company Information Table 78. Hikma Business Overview Table 79. Hikma Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 80. Hikma Ketorolac Injection Product Portfolio Table 81. Hikma Recent Development Table 82. Lunan Pharma Company Information Table 83. Lunan Pharma Business Overview Table 84. Lunan Pharma Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 85. Lunan Pharma Ketorolac Injection Product Portfolio Table 86. Lunan Pharma Recent Development Table 87. Alvogen Company Information Table 88. Alvogen Business Overview Table 89. Alvogen Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 90. Alvogen Ketorolac Injection Product Portfolio Table 91. Alvogen Recent Development Table 92. Chengdu Brilliant Pharmaceuticals Company Information Table 93. Chengdu Brilliant Pharmaceuticals Business Overview Table 94. Chengdu Brilliant Pharmaceuticals Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 95. Chengdu Brilliant Pharmaceuticals Ketorolac Injection Product Portfolio Table 96. Chengdu Brilliant Pharmaceuticals Recent Development Table 97. Athenex Company Information Table 98. Athenex Business Overview Table 99. Athenex Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 100. Athenex Ketorolac Injection Product Portfolio Table 101. Athenex Recent Development Table 102. Sichuan Medcalo Company Information Table 103. Sichuan Medcalo Business Overview Table 104. Sichuan Medcalo Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 105. Sichuan Medcalo Ketorolac Injection Product Portfolio Table 106. Sichuan Medcalo Recent Development Table 107. Julphar Bangladesh Ltd. Company Information Table 108. Julphar Bangladesh Ltd. Business Overview Table 109. Julphar Bangladesh Ltd. Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 110. Julphar Bangladesh Ltd. Ketorolac Injection Product Portfolio Table 111. Julphar Bangladesh Ltd. Recent Development Table 112. Yung Shin Pharm Company Information Table 113. Yung Shin Pharm Business Overview Table 114. Yung Shin Pharm Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 115. Yung Shin Pharm Ketorolac Injection Product Portfolio Table 116. Yung Shin Pharm Recent Development Table 117. Tianjin Chase Sun Pharmaceutical Company Information Table 118. Tianjin Chase Sun Pharmaceutical Business Overview Table 119. Tianjin Chase Sun Pharmaceutical Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 120. Tianjin Chase Sun Pharmaceutical Ketorolac Injection Product Portfolio Table 121. Tianjin Chase Sun Pharmaceutical Recent Development Table 122. ZISKA Pharmaceuticals Company Information Table 123. ZISKA Pharmaceuticals Business Overview Table 124. ZISKA Pharmaceuticals Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 125. ZISKA Pharmaceuticals Ketorolac Injection Product Portfolio Table 126. ZISKA Pharmaceuticals Recent Development Table 127. North America Ketorolac Injection Revenue by Concentration (2021-2026) & (US$ Million) Table 128. North America Ketorolac Injection Revenue by Concentration (2027-2032) & (US$ Million) Table 129. North America Ketorolac Injection Sales by Concentration (2021-2026) & (K Units) Table 130. North America Ketorolac Injection Sales by Concentration (2027-2032) & (K Units) Table 131. North America Ketorolac Injection Sales Price by Concentration (2021-2026) & (US$/K Units) Table 132. North America Ketorolac Injection Sales Price by Concentration (2027-2032) & (US$/K Units) Table 133. North America Ketorolac Injection Revenue by Application (2021-2026) & (US$ Million) Table 134. North America Ketorolac Injection Revenue by Application (2027-2032) & (US$ Million) Table 135. North America Ketorolac Injection Sales by Application (2021-2026) & (K Units) Table 136. North America Ketorolac Injection Sales by Application (2027-2032) & (K Units) Table 137. North America Ketorolac Injection Sales Price by Application (2021-2026) & (US$/K Units) Table 138. North America Ketorolac Injection Sales Price by Application (2027-2032) & (US$/K Units) Table 139. North America Ketorolac Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. North America Ketorolac Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 141. North America Ketorolac Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 142. North America Ketorolac Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 143. North America Ketorolac Injection Sales by Country (2021-2026) & (K Units) Table 144. North America Ketorolac Injection Sales by Country (2027-2032) & (K Units) Table 145. North America Ketorolac Injection Sales Price by Country (2021-2026) & (US$/K Units) Table 146. North America Ketorolac Injection Sales Price by Country (2027-2032) & (US$/K Units) Table 147. United States Ketorolac Injection Revenue (2021-2032) & (US$ Million) Table 148. Canada Ketorolac Injection Revenue (2021-2032) & (US$ Million) Table 149. Mexico Ketorolac Injection Revenue (2021-2032) & (US$ Million) Table 150. Europe Ketorolac Injection Revenue by Concentration (2021-2026) & (US$ Million) Table 151. Europe Ketorolac Injection Revenue by Concentration (2027-2032) & (US$ Million) Table 152. Europe Ketorolac Injection Sales by Concentration (2021-2026) & (K Units) Table 153. Europe Ketorolac Injection Sales by Concentration (2027-2032) & (K Units) Table 154. Europe Ketorolac Injection Sales Price by Concentration (2021-2026) & (US$/K Units) Table 155. Europe Ketorolac Injection Sales Price by Concentration (2027-2032) & (US$/K Units) Table 156. Europe Ketorolac Injection Revenue by Application (2021-2026) & (US$ Million) Table 157. Europe Ketorolac Injection Revenue by Application (2027-2032) & (US$ Million) Table 158. Europe Ketorolac Injection Sales by Application (2021-2026) & (K Units) Table 159. Europe Ketorolac Injection Sales by Application (2027-2032) & (K Units) Table 160. Europe Ketorolac Injection Sales Price by Application (2021-2026) & (US$/K Units) Table 161. Europe Ketorolac Injection Sales Price by Application (2027-2032) & (US$/K Units) Table 162. Europe Ketorolac Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 163. Europe Ketorolac Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 164. Europe Ketorolac Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 165. Europe Ketorolac Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 166. Europe Ketorolac Injection Sales by Country (2021-2026) & (K Units) Table 167. Europe Ketorolac Injection Sales by Country (2027-2032) & (K Units) Table 168. Europe Ketorolac Injection Sales Price by Country (2021-2026) & (US$/K Units) Table 169. Europe Ketorolac Injection Sales Price by Country (2027-2032) & (US$/K Units) Table 170. Germany Ketorolac Injection Revenue (2021-2032) & (US$ Million) Table 171. France Ketorolac Injection Revenue (2021-2032) & (US$ Million) Table 172. U.K. Ketorolac Injection Revenue (2021-2032) & (US$ Million) Table 173. Italy Ketorolac Injection Revenue (2021-2032) & (US$ Million) Table 174. Russia Ketorolac Injection Revenue (2021-2032) & (US$ Million) Table 175. Spain Ketorolac Injection Revenue (2021-2032) & (US$ Million) Table 176. Netherlands Ketorolac Injection Revenue (2021-2032) & (US$ Million) Table 177. Switzerland Ketorolac Injection Revenue (2021-2032) & (US$ Million) Table 178. Sweden Ketorolac Injection Revenue (2021-2032) & (US$ Million) Table 179. Poland Ketorolac Injection Revenue (2021-2032) & (US$ Million) Table 180. China Ketorolac Injection Revenue by Concentration (2021-2026) & (US$ Million) Table 181. China Ketorolac Injection Revenue by Concentration (2027-2032) & (US$ Million) Table 182. China Ketorolac Injection Sales by Concentration (2021-2026) & (K Units) Table 183. China Ketorolac Injection Sales by Concentration (2027-2032) & (K Units) Table 184. China Ketorolac Injection Sales Price by Concentration (2021-2026) & (US$/K Units) Table 185. China Ketorolac Injection Sales Price by Concentration (2027-2032) & (US$/K Units) Table 186. China Ketorolac Injection Revenue by Application (2021-2026) & (US$ Million) Table 187. China Ketorolac Injection Revenue by Application (2027-2032) & (US$ Million) Table 188. China Ketorolac Injection Sales by Application (2021-2026) & (K Units) Table 189. China Ketorolac Injection Sales by Application (2027-2032) & (K Units) Table 190. China Ketorolac Injection Sales Price by Application (2021-2026) & (US$/K Units) Table 191. China Ketorolac Injection Sales Price by Application (2027-2032) & (US$/K Units) Table 192. Asia Ketorolac Injection Revenue by Concentration (2021-2026) & (US$ Million) Table 193. Asia Ketorolac Injection Revenue by Concentration (2027-2032) & (US$ Million) Table 194. Asia Ketorolac Injection Sales by Concentration (2021-2026) & (K Units) Table 195. Asia Ketorolac Injection Sales by Concentration (2027-2032) & (K Units) Table 196. Asia Ketorolac Injection Sales Price by Concentration (2021-2026) & (US$/K Units) Table 197. Asia Ketorolac Injection Sales Price by Concentration (2027-2032) & (US$/K Units) Table 198. Asia Ketorolac Injection Revenue by Application (2021-2026) & (US$ Million) Table 199. Asia Ketorolac Injection Revenue by Application (2027-2032) & (US$ Million) Table 200. Asia Ketorolac Injection Sales by Application (2021-2026) & (K Units) Table 201. Asia Ketorolac Injection Sales by Application (2027-2032) & (K Units) Table 202. Asia Ketorolac Injection Sales Price by Application (2021-2026) & (US$/K Units) Table 203. Asia Ketorolac Injection Sales Price by Application (2027-2032) & (US$/K Units) Table 204. Asia Ketorolac Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 205. Asia Ketorolac Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 206. Asia Ketorolac Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 207. Asia Ketorolac Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 208. Asia Ketorolac Injection Sales by Country (2021-2026) & (K Units) Table 209. Asia Ketorolac Injection Sales by Country (2027-2032) & (K Units) Table 210. Asia Ketorolac Injection Sales Price by Country (2021-2026) & (US$/K Units) Table 211. Asia Ketorolac Injection Sales Price by Country (2027-2032) & (US$/K Units) Table 212. Japan Ketorolac Injection Revenue (2021-2032) & (US$ Million) Table 213. South Korea Ketorolac Injection Revenue (2021-2032) & (US$ Million) Table 214. India Ketorolac Injection Revenue (2021-2032) & (US$ Million) Table 215. Australia Ketorolac Injection Revenue (2021-2032) & (US$ Million) Table 216. Taiwan Ketorolac Injection Revenue (2021-2032) & (US$ Million) Table 217. Southeast Asia Ketorolac Injection Revenue (2021-2032) & (US$ Million) Table 218. SAMEA Ketorolac Injection Revenue by Concentration (2021-2026) & (US$ Million) Table 219. SAMEA Ketorolac Injection Revenue by Concentration (2027-2032) & (US$ Million) Table 220. SAMEA Ketorolac Injection Sales by Concentration (2021-2026) & (K Units) Table 221. SAMEA Ketorolac Injection Sales by Concentration (2027-2032) & (K Units) Table 222. SAMEA Ketorolac Injection Sales Price by Concentration (2021-2026) & (US$/K Units) Table 223. SAMEA Ketorolac Injection Sales Price by Concentration (2027-2032) & (US$/K Units) Table 224. SAMEA Ketorolac Injection Revenue by Application (2021-2026) & (US$ Million) Table 225. SAMEA Ketorolac Injection Revenue by Application (2027-2032) & (US$ Million) Table 226. SAMEA Ketorolac Injection Sales by Application (2021-2026) & (K Units) Table 227. SAMEA Ketorolac Injection Sales by Application (2027-2032) & (K Units) Table 228. SAMEA Ketorolac Injection Sales Price by Application (2021-2026) & (US$/K Units) Table 229. SAMEA Ketorolac Injection Sales Price by Application (2027-2032) & (US$/K Units) Table 230. SAMEA Ketorolac Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 231. SAMEA Ketorolac Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 232. SAMEA Ketorolac Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 233. SAMEA Ketorolac Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 234. SAMEA Ketorolac Injection Sales by Country (2021-2026) & (K Units) Table 235. SAMEA Ketorolac Injection Sales by Country (2027-2032) & (K Units) Table 236. SAMEA Ketorolac Injection Sales Price by Country (2021-2026) & (US$/K Units) Table 237. SAMEA Ketorolac Injection Sales Price by Country (2027-2032) & (US$/K Units) Table 238. Brazil Ketorolac Injection Revenue (2021-2032) & (US$ Million) Table 239. Argentina Ketorolac Injection Revenue (2021-2032) & (US$ Million) Table 240. Chile Ketorolac Injection Revenue (2021-2032) & (US$ Million) Table 241. Colombia Ketorolac Injection Revenue (2021-2032) & (US$ Million) Table 242. Peru Ketorolac Injection Revenue (2021-2032) & (US$ Million) Table 243. Saudi Arabia Ketorolac Injection Revenue (2021-2032) & (US$ Million) Table 244. Israel Ketorolac Injection Revenue (2021-2032) & (US$ Million) Table 245. UAE Ketorolac Injection Revenue (2021-2032) & (US$ Million) Table 246. Turkey Ketorolac Injection Revenue (2021-2032) & (US$ Million) Table 247. Iran Ketorolac Injection Revenue (2021-2032) & (US$ Million) Table 248. Egypt Ketorolac Injection Revenue (2021-2032) & (US$ Million) Table 249. Key Raw Materials Table 250. Raw Materials Key Suppliers Table 251. Ketorolac Injection Distributors List Table 252. Ketorolac Injection Customers List Table 253. Research Programs/Design for This Report Table 254. Authors List of This Report Table 255. Secondary Sources Table 256. Primary Sources List of Figures Figure 1. Ketorolac Injection Image Figure 2. Global Ketorolac Injection Market Size Growth Rate by Concentration (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ketorolac Injection Market Size Share 2021 VS 2025 VS 2032 Figure 4. 15mg/ml Image Figure 5. 30mg/ml Image Figure 6. Global Ketorolac Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Ketorolac Injection Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinics Image Figure 10. Others Image Figure 11. Global Ketorolac Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Ketorolac Injection Revenue (2021-2032) & (US$ Million) Figure 13. Global Ketorolac Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Ketorolac Injection Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Ketorolac Injection Revenue Market Share by Region (2021-2032) Figure 16. Global Ketorolac Injection Sales (2021-2032) & (K Units) Figure 17. Global Ketorolac Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Ketorolac Injection Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Ketorolac Injection Sales YoY (2021-2032) & (K Units) Figure 20. Europe Ketorolac Injection Sales YoY (2021-2032) & (K Units) Figure 21. China Ketorolac Injection Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Ketorolac Injection Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Ketorolac Injection Sales YoY (2021-2032) & (K Units) Figure 24. Global Ketorolac Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Ketorolac Injection Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Ketorolac Injection Revenue by Concentration (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Ketorolac Injection Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Ketorolac Injection Revenue Market Share by Concentration (2021-2032) Figure 30. Global Ketorolac Injection Sales by Concentration (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Ketorolac Injection Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Ketorolac Injection Sales Market Share by Concentration (2021-2032) Figure 33. Global Ketorolac Injection Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Ketorolac Injection Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Ketorolac Injection Revenue Market Share by Application (2021-2032) Figure 36. Global Ketorolac Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Ketorolac Injection Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Ketorolac Injection Sales Market Share by Application (2021-2032) Figure 39. North America Ketorolac Injection Revenue Share by Concentration (2021-2032) Figure 40. North America Ketorolac Injection Sales Share by Concentration (2021-2032) Figure 41. North America Ketorolac Injection Revenue Share by Application (2021-2032) Figure 42. North America Ketorolac Injection Sales Share by Application (2021-2032) Figure 43. North America Ketorolac Injection Revenue Share by Country (2021-2032) Figure 44. North America Ketorolac Injection Sales Share by Country (2021-2032) Figure 45. Europe Ketorolac Injection Revenue Share by Concentration (2021-2032) Figure 46. Europe Ketorolac Injection Sales Share by Concentration (2021-2032) Figure 47. Europe Ketorolac Injection Revenue Share by Application (2021-2032) Figure 48. Europe Ketorolac Injection Sales Share by Application (2021-2032) Figure 49. Europe Ketorolac Injection Revenue Share by Country (2021-2032) Figure 50. Europe Ketorolac Injection Sales Share by Country (2021-2032) Figure 51. China Ketorolac Injection Revenue Share by Concentration (2021-2032) Figure 52. China Ketorolac Injection Sales Share by Concentration (2021-2032) Figure 53. China Ketorolac Injection Revenue Share by Application (2021-2032) Figure 54. China Ketorolac Injection Sales Share by Application (2021-2032) Figure 55. Asia Ketorolac Injection Revenue Share by Concentration (2021-2032) Figure 56. Asia Ketorolac Injection Sales Share by Concentration (2021-2032) Figure 57. Asia Ketorolac Injection Revenue Share by Application (2021-2032) Figure 58. Asia Ketorolac Injection Sales Share by Application (2021-2032) Figure 59. Asia Ketorolac Injection Revenue Share by Country (2021-2032) Figure 60. Asia Ketorolac Injection Sales Share by Country (2021-2032) Figure 61. SAMEA Ketorolac Injection Revenue Share by Concentration (2021-2032) Figure 62. SAMEA Ketorolac Injection Sales Share by Concentration (2021-2032) Figure 63. SAMEA Ketorolac Injection Revenue Share by Application (2021-2032) Figure 64. SAMEA Ketorolac Injection Sales Share by Application (2021-2032) Figure 65. SAMEA Ketorolac Injection Revenue Share by Country (2021-2032) Figure 66. SAMEA Ketorolac Injection Sales Share by Country (2021-2032) Figure 67. Ketorolac Injection Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Ketorolac Injection Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 15mg/ml
  • 30mg/ml
Applications
  • Hospital
  • Clinics
  • Others
Companies covered
  • Pfizer
  • Fresenius Kabi
  • Fosun Pharma (Gland Pharma)
  • Sagent Pharmaceuticals
  • Hikma
  • Lunan Pharma
  • Alvogen
  • Chengdu Brilliant Pharmaceuticals
  • Athenex
  • Sichuan Medcalo
  • Julphar Bangladesh Ltd.
  • Yung Shin Pharm
  • Tianjin Chase Sun Pharmaceutical
  • ZISKA Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Ketorolac Injection Market by Concentration
  3. 1.2.1 Global Ketorolac Injection Market Size by Concentration, 2021 VS 2025 VS 2032
  4. 1.2.2 15mg/ml
  5. 1.2.3 30mg/ml
  6. 1.3 Ketorolac Injection Market by Application
  7. 1.3.1 Global Ketorolac Injection Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinics
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Ketorolac Injection Market Dynamics
  1. 2.1 Ketorolac Injection Industry Trends
  2. 2.2 Ketorolac Injection Industry Drivers
  3. 2.3 Ketorolac Injection Industry Opportunities and Challenges
  4. 2.4 Ketorolac Injection Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Ketorolac Injection Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Ketorolac Injection Revenue by Region
  3. 3.2.1 Global Ketorolac Injection Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Ketorolac Injection Revenue by Region (2021-2026)
  5. 3.2.3 Global Ketorolac Injection Revenue by Region (2027-2032)
  6. 3.2.4 Global Ketorolac Injection Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Ketorolac Injection Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Ketorolac Injection Sales by Region
  9. 3.4.1 Global Ketorolac Injection Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Ketorolac Injection Sales by Region (2021-2026)
  11. 3.4.3 Global Ketorolac Injection Sales by Region (2027-2032)
  12. 3.4.4 Global Ketorolac Injection Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Ketorolac Injection Revenue by Manufacturers
  2. 4.1.1 Global Ketorolac Injection Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Ketorolac Injection Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Ketorolac Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Ketorolac Injection Sales by Manufacturers
  6. 4.2.1 Global Ketorolac Injection Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Ketorolac Injection Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Ketorolac Injection Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Ketorolac Injection Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Ketorolac Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Ketorolac Injection Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Ketorolac Injection Manufacturers, Product Type & Application
  13. 4.7 Global Ketorolac Injection Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Ketorolac Injection Market CR5 and HHI
  16. 4.8.2 2025 Ketorolac Injection Tier 1, Tier 2, and Tier 3
5 Ketorolac Injection Market by Type
  1. 5.1 Global Ketorolac Injection Revenue by Type
  2. 5.1.1 Global Ketorolac Injection Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Ketorolac Injection Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Ketorolac Injection Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Ketorolac Injection Sales by Type
  6. 5.2.1 Global Ketorolac Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Ketorolac Injection Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Ketorolac Injection Sales Market Share by Type (2021-2032)
  9. 5.3 Global Ketorolac Injection Price by Type
6 Ketorolac Injection Market by Application
  1. 6.1 Global Ketorolac Injection Revenue by Application
  2. 6.1.1 Global Ketorolac Injection Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Ketorolac Injection Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Ketorolac Injection Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Ketorolac Injection Sales by Application
  6. 6.2.1 Global Ketorolac Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Ketorolac Injection Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Ketorolac Injection Sales Market Share by Application (2021-2032)
  9. 6.3 Global Ketorolac Injection Price by Application
7 Company Profiles
  1. 7.1 Pfizer
  2. 7.1.1 Pfizer Company Information
  3. 7.1.2 Pfizer Business Overview
  4. 7.1.3 Pfizer Ketorolac Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Pfizer Ketorolac Injection Product Portfolio
  6. 7.1.5 Pfizer Recent Developments
  7. 7.2 Fresenius Kabi
  8. 7.2.1 Fresenius Kabi Company Information
  9. 7.2.2 Fresenius Kabi Business Overview
  10. 7.2.3 Fresenius Kabi Ketorolac Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Fresenius Kabi Ketorolac Injection Product Portfolio
  12. 7.2.5 Fresenius Kabi Recent Developments
  13. 7.3 Fosun Pharma (Gland Pharma)
  14. 7.3.1 Fosun Pharma (Gland Pharma) Company Information
  15. 7.3.2 Fosun Pharma (Gland Pharma) Business Overview
  16. 7.3.3 Fosun Pharma (Gland Pharma) Ketorolac Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Fosun Pharma (Gland Pharma) Ketorolac Injection Product Portfolio
  18. 7.3.5 Fosun Pharma (Gland Pharma) Recent Developments
  19. 7.4 Sagent Pharmaceuticals
  20. 7.4.1 Sagent Pharmaceuticals Company Information
  21. 7.4.2 Sagent Pharmaceuticals Business Overview
  22. 7.4.3 Sagent Pharmaceuticals Ketorolac Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Sagent Pharmaceuticals Ketorolac Injection Product Portfolio
  24. 7.4.5 Sagent Pharmaceuticals Recent Developments
  25. 7.5 Hikma
  26. 7.5.1 Hikma Company Information
  27. 7.5.2 Hikma Business Overview
  28. 7.5.3 Hikma Ketorolac Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Hikma Ketorolac Injection Product Portfolio
  30. 7.5.5 Hikma Recent Developments
  31. 7.6 Lunan Pharma
  32. 7.6.1 Lunan Pharma Company Information
  33. 7.6.2 Lunan Pharma Business Overview
  34. 7.6.3 Lunan Pharma Ketorolac Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Lunan Pharma Ketorolac Injection Product Portfolio
  36. 7.6.5 Lunan Pharma Recent Developments
  37. 7.7 Alvogen
  38. 7.7.1 Alvogen Company Information
  39. 7.7.2 Alvogen Business Overview
  40. 7.7.3 Alvogen Ketorolac Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Alvogen Ketorolac Injection Product Portfolio
  42. 7.7.5 Alvogen Recent Developments
  43. 7.8 Chengdu Brilliant Pharmaceuticals
  44. 7.8.1 Chengdu Brilliant Pharmaceuticals Company Information
  45. 7.8.2 Chengdu Brilliant Pharmaceuticals Business Overview
  46. 7.8.3 Chengdu Brilliant Pharmaceuticals Ketorolac Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Chengdu Brilliant Pharmaceuticals Ketorolac Injection Product Portfolio
  48. 7.8.5 Chengdu Brilliant Pharmaceuticals Recent Developments
  49. 7.9 Athenex
  50. 7.9.1 Athenex Company Information
  51. 7.9.2 Athenex Business Overview
  52. 7.9.3 Athenex Ketorolac Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Athenex Ketorolac Injection Product Portfolio
  54. 7.9.5 Athenex Recent Developments
  55. 7.10 Sichuan Medcalo
  56. 7.10.1 Sichuan Medcalo Company Information
  57. 7.10.2 Sichuan Medcalo Business Overview
  58. 7.10.3 Sichuan Medcalo Ketorolac Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Sichuan Medcalo Ketorolac Injection Product Portfolio
  60. 7.10.5 Sichuan Medcalo Recent Developments
  61. 7.11 Julphar Bangladesh Ltd.
  62. 7.11.1 Julphar Bangladesh Ltd. Company Information
  63. 7.11.2 Julphar Bangladesh Ltd. Business Overview
  64. 7.11.3 Julphar Bangladesh Ltd. Ketorolac Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Julphar Bangladesh Ltd. Ketorolac Injection Product Portfolio
  66. 7.11.5 Julphar Bangladesh Ltd. Recent Developments
  67. 7.12 Yung Shin Pharm
  68. 7.12.1 Yung Shin Pharm Company Information
  69. 7.12.2 Yung Shin Pharm Business Overview
  70. 7.12.3 Yung Shin Pharm Ketorolac Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Yung Shin Pharm Ketorolac Injection Product Portfolio
  72. 7.12.5 Yung Shin Pharm Recent Developments
  73. 7.13 Tianjin Chase Sun Pharmaceutical
  74. 7.13.1 Tianjin Chase Sun Pharmaceutical Company Information
  75. 7.13.2 Tianjin Chase Sun Pharmaceutical Business Overview
  76. 7.13.3 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Product Portfolio
  78. 7.13.5 Tianjin Chase Sun Pharmaceutical Recent Developments
  79. 7.14 ZISKA Pharmaceuticals
  80. 7.14.1 ZISKA Pharmaceuticals Company Information
  81. 7.14.2 ZISKA Pharmaceuticals Business Overview
  82. 7.14.3 ZISKA Pharmaceuticals Ketorolac Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 ZISKA Pharmaceuticals Ketorolac Injection Product Portfolio
  84. 7.14.5 ZISKA Pharmaceuticals Recent Developments
8 North America
  1. 8.1 North America Ketorolac Injection Market Size by Concentration
  2. 8.1.1 North America Ketorolac Injection Revenue by Concentration (2021-2032)
  3. 8.1.2 North America Ketorolac Injection Sales by Concentration (2021-2032)
  4. 8.1.3 North America Ketorolac Injection Price by Concentration (2021-2032)
  5. 8.2 North America Ketorolac Injection Market Size by Application
  6. 8.2.1 North America Ketorolac Injection Revenue by Application (2021-2032)
  7. 8.2.2 North America Ketorolac Injection Sales by Application (2021-2032)
  8. 8.2.3 North America Ketorolac Injection Price by Application (2021-2032)
  9. 8.3 North America Ketorolac Injection Market Size by Country
  10. 8.3.1 North America Ketorolac Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Ketorolac Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Ketorolac Injection Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Ketorolac Injection Market Size by Concentration
  2. 9.1.1 Europe Ketorolac Injection Revenue by Concentration (2021-2032)
  3. 9.1.2 Europe Ketorolac Injection Sales by Concentration (2021-2032)
  4. 9.1.3 Europe Ketorolac Injection Price by Concentration (2021-2032)
  5. 9.2 Europe Ketorolac Injection Market Size by Application
  6. 9.2.1 Europe Ketorolac Injection Revenue by Application (2021-2032)
  7. 9.2.2 Europe Ketorolac Injection Sales by Application (2021-2032)
  8. 9.2.3 Europe Ketorolac Injection Price by Application (2021-2032)
  9. 9.3 Europe Ketorolac Injection Market Size by Country
  10. 9.3.1 Europe Ketorolac Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Ketorolac Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Ketorolac Injection Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Ketorolac Injection Market Size by Concentration
  2. 10.1.1 China Ketorolac Injection Revenue by Concentration (2021-2032)
  3. 10.1.2 China Ketorolac Injection Sales by Concentration (2021-2032)
  4. 10.1.3 China Ketorolac Injection Price by Concentration (2021-2032)
  5. 10.2 China Ketorolac Injection Market Size by Application
  6. 10.2.1 China Ketorolac Injection Revenue by Application (2021-2032)
  7. 10.2.2 China Ketorolac Injection Sales by Application (2021-2032)
  8. 10.2.3 China Ketorolac Injection Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Ketorolac Injection Market Size by Concentration
  2. 11.1.1 Asia Ketorolac Injection Revenue by Concentration (2021-2032)
  3. 11.1.2 Asia Ketorolac Injection Sales by Concentration (2021-2032)
  4. 11.1.3 Asia Ketorolac Injection Price by Concentration (2021-2032)
  5. 11.2 Asia Ketorolac Injection Market Size by Application
  6. 11.2.1 Asia Ketorolac Injection Revenue by Application (2021-2032)
  7. 11.2.2 Asia Ketorolac Injection Sales by Application (2021-2032)
  8. 11.2.3 Asia Ketorolac Injection Price by Application (2021-2032)
  9. 11.3 Asia Ketorolac Injection Market Size by Country
  10. 11.3.1 Asia Ketorolac Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Ketorolac Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Ketorolac Injection Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Ketorolac Injection Market Size by Concentration
  2. 12.1.1 SAMEA Ketorolac Injection Revenue by Concentration (2021-2032)
  3. 12.1.2 SAMEA Ketorolac Injection Sales by Concentration (2021-2032)
  4. 12.1.3 SAMEA Ketorolac Injection Price by Concentration (2021-2032)
  5. 12.2 SAMEA Ketorolac Injection Market Size by Application
  6. 12.2.1 SAMEA Ketorolac Injection Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Ketorolac Injection Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Ketorolac Injection Price by Application (2021-2032)
  9. 12.3 SAMEA Ketorolac Injection Market Size by Country
  10. 12.3.1 SAMEA Ketorolac Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Ketorolac Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Ketorolac Injection Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Ketorolac Injection Value Chain Analysis
  2. 13.1.1 Ketorolac Injection Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Ketorolac Injection Production Mode & Process
  6. 13.2 Ketorolac Injection Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Ketorolac Injection Distributors
  9. 13.2.3 Ketorolac Injection Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst